{"entity":{"id":"paper-sauvaget-thermal-ablation-burundi-ijc-2022","kind":"paper","name":"Thermal ablation for cervical neoplasia in Burundi: effectiveness, acceptability and safety","aka":[],"tldr":"In Burundi, 86 women with early changes in the cervix found by visual inspection were treated by thermal ablation, a short heat treatment. A year later 96% of the women examined were free of the changes, and no serious harm was reported.","summary":"Published as \"Evaluation of effectiveness, acceptability and safety of thermal ablation in the treatment of cervical neoplasia in Burundi\", with a first author at the International Agency for Research on Cancer. Women referred to a gynaecology ward for symptoms or opportunistic screening were assessed by visual inspection with acetic acid and colposcopy; those with lesions eligible for ablation were counselled and treated, asked about pain and satisfaction, followed up at six weeks and reassessed at 12 months. The study is registered as NCT05211271, sponsored by the agency, with Kamenge University Hospital in Bujumbura as its site.","asOf":"2026-11-16","links":[{"label":"International Journal of Cancer 2022","url":"https://doi.org/10.1002/ijc.34117"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/35567576/"},{"label":"ClinicalTrials.gov: NCT05211271","url":"https://clinicaltrials.gov/study/NCT05211271"}],"tags":[],"related":[],"cancers":["cervical"],"sections":[],"technologies":["via-cervical-screening"],"targets":[],"drugs":[],"companies":[],"institutions":["iarc","chu-kamenge"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"journal":"International Journal of Cancer","year":2022,"doi":"10.1002/ijc.34117","pmid":"35567576","authors":"Sauvaget C, Bazikamwe S, Lucas E, et al.","paperType":"observational","findings":["86 women with a positive visual inspection were included; the mean age was 46 years (range 28 to 61).","At 12 months 82 women were examined (95% follow-up) and the overall cure rate was 96%: 98% for low-grade and 94% for high-grade lesions.","One third had mild pain or cramp during treatment; watery discharge was the main event at six weeks; no major adverse event or hospitalisation was reported."],"whatItMeans":"This study shows thermal ablation working in Burundi with a high cure rate at one year. The national cancer plan for 2024 to 2028 builds on screening and treating early cervical changes, in a country with no radiotherapy for invasive cervical cancer.","caveats":["A single-arm study of 86 women with one year of follow-up; there was no comparison group.","The abstract does not name the hospital; the registry record does."],"participants":86},"route":"/key-papers/paper-sauvaget-thermal-ablation-burundi-ijc-2022/","neighbours":{"cancer":[{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"}],"technology":[{"id":"via-cervical-screening","kind":"technology","name":"Visual inspection with acetic acid (VIA) for cervical screening","route":"/technologies/via-cervical-screening/"}],"institution":[{"id":"chu-kamenge","kind":"institution","name":"Centre Hospitalo-Universitaire de Kamenge (CHUK)","route":"/institutions/chu-kamenge/"},{"id":"iarc","kind":"institution","name":"International Agency for Research on Cancer (IARC / WHO)","route":"/institutions/iarc/"}]}}